Literature DB >> 20887619

Extremely high brain natriuretic peptide does not reflect the severity of heart failure.

Catherine Law1, Charles Glover, Kaaron Benson, Maya Guglin.   

Abstract

Brain natriuretic peptide (BNP) is important in the diagnosis and management of heart failure (HF). Sometimes, very high BNP levels encountered in clinical settings seem to be out of proportion to the severity of HF. The authors retrospectively identified 113 patients with 129 admissions with a BNP value >3000 pg/mL regardless of diagnosis. The data set was analyzed using the Student t test and bivariate analysis. Fewer than half of patients were admitted for HF. In 14 patients (10.9%), no signs of HF were found. The BNP level of those with and without HF was similar. There was no difference in BNP level in patients with and without systolic dysfunction or renal dysfunction and between different age groups. Extreme values of BNP do not necessarily correlate with the presence of HF, cardiomyopathy, or kidney dysfunction. When the magnitude of BNP elevation is very high, its clinical significance is limited.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20887619     DOI: 10.1111/j.1751-7133.2010.00178.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  9 in total

Review 1.  Non-Invasive Assessment of Congestion by Cardiovascular and Pulmonary Ultrasound and Biomarkers in Heart Failure.

Authors:  Adriana Mihaela Ilieșiu; Andreea Simona Hodorogea; Ana-Maria Balahura; Elisabeta Bădilă
Journal:  Diagnostics (Basel)       Date:  2022-04-12

2.  Medication adherence, depressive symptoms, and cardiac event-free survival in patients with heart failure.

Authors:  Jia-Rong Wu; Terry A Lennie; Rebecca L Dekker; Martha J Biddle; Debra K Moser
Journal:  J Card Fail       Date:  2013-05       Impact factor: 5.712

3.  Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting.

Authors:  Salvatore Di Somma; Martin Magnusson; John Molvin; Amra Jujic; Silvia Navarin; Olle Melander; Giada Zoccoli; Oliver Hartmann; Andreas Bergmann; Joachim Struck; Erasmus Bachus
Journal:  Open Heart       Date:  2019-07-03

4.  Severe multisystem organ dysfunction in an adolescent with simultaneous presentation of Addison's and Graves' disease.

Authors:  Bethany Graulich; Krystal Irizarry; Craig Orlowski; Carol A Wittlieb-Weber; David R Weber
Journal:  J Pediatr Endocrinol Metab       Date:  2020-12-15       Impact factor: 1.634

5.  Association of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients.

Authors:  Hua Cui; Guoliang Huo; Lin Liu; Li Fan; Ping Ye; Jian Cao; Yongyi Bai; Fan Wang; Yixin Hu
Journal:  BMC Cardiovasc Disord       Date:  2012-07-26       Impact factor: 2.298

6.  Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levels.

Authors:  Hai-Yan Pan; Jian-Hua Zhu; Yong Gu; Xiao-Hong Yu; Min Pan; Hong-Yin Niu
Journal:  BMC Cardiovasc Disord       Date:  2014-03-04       Impact factor: 2.298

7.  Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.

Authors:  P R Fox; M A Oyama; M J Hezzell; J E Rush; T P Nguyenba; T C DeFrancesco; L B Lehmkuhl; H B Kellihan; B Bulmer; S G Gordon; S M Cunningham; J MacGregor; R L Stepien; B Lefbom; D Adin; K Lamb
Journal:  J Vet Intern Med       Date:  2014-10-10       Impact factor: 3.333

8.  Anisotropic engineered heart tissue made from laser-cut decellularized myocardium.

Authors:  Jonas Schwan; Andrea T Kwaczala; Thomas J Ryan; Oscar Bartulos; Yongming Ren; Lorenzo R Sewanan; Aaron H Morris; Daniel L Jacoby; Yibing Qyang; Stuart G Campbell
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

Review 9.  Subclinical cardiac damage in cancer patients before chemotherapy.

Authors:  Iacopo Fabiani; Giorgia Panichella; Alberto Aimo; Chrysanthos Grigoratos; Giuseppe Vergaro; Nicola Riccardo Pugliese; Stefano Taddei; Daniela Maria Cardinale; Claudio Passino; Michele Emdin; Alberto Giannoni
Journal:  Heart Fail Rev       Date:  2021-07-27       Impact factor: 4.654

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.